跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REDDY-DASATINIB - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
REDDY-DASATINIB
Authorized
STANDARD
REDDY-DASATINIB
dr reddy's laboratories ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
69cfd846dee7c204
Company
dr reddy's laboratories ltd
Type
Standard
Approval Details
Approval Id
69cfd846dee7c204
Drug Approval Canada Name
REDDY-DASATINIB
Product Name
REDDY-DASATINIB
Status
Marketed
Status Date
2021-09-16
Original Market Date
2021-09-16
Din
02514737
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01EA02 DASATINIB
Atc Name
l 01 ea 02
Aig Number
0152198001
Company Name
dr reddy's laboratories ltd
Company Address
Survey Nos. 42, 45, 46 & 54, Innovation Plaza, Bachupally, Medchal-Malkajgiri, Telangana, India, 500090
Active Ingredients
DASATINIB (DASATINIB (S)-PROPYLENE GLYCOL)
20 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
69cfd846dee7c204
Type
Standard
Back to Health Canada Approvals